Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 48 studies | 45% ± 16% | |
| pericyte | 22 studies | 41% ± 19% | |
| capillary endothelial cell | 16 studies | 56% ± 13% | |
| endothelial cell of artery | 14 studies | 45% ± 14% | |
| endothelial cell of lymphatic vessel | 13 studies | 25% ± 8% | |
| type I pneumocyte | 12 studies | 40% ± 10% | |
| type II pneumocyte | 12 studies | 54% ± 17% | |
| endothelial cell of vascular tree | 11 studies | 33% ± 20% | |
| smooth muscle cell | 9 studies | 26% ± 8% | |
| vein endothelial cell | 8 studies | 23% ± 7% | |
| renal alpha-intercalated cell | 7 studies | 83% ± 10% | |
| ionocyte | 6 studies | 53% ± 15% | |
| endothelial cell of sinusoid | 4 studies | 44% ± 21% | |
| glomerular endothelial cell | 4 studies | 87% ± 3% | |
| epithelial cell | 4 studies | 20% ± 4% | |
| club cell | 4 studies | 44% ± 9% | |
| ciliated cell | 3 studies | 21% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 6 studies | 24% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 10202.08 | 653 / 653 | 89% | 54.86 | 536 / 605 |
| breast | 100% | 13502.95 | 459 / 459 | 86% | 19.32 | 960 / 1118 |
| lung | 100% | 24210.55 | 578 / 578 | 84% | 68.44 | 968 / 1155 |
| adrenal gland | 99% | 4647.41 | 255 / 258 | 80% | 25.03 | 185 / 230 |
| kidney | 100% | 14392.34 | 89 / 89 | 76% | 87.43 | 688 / 901 |
| brain | 66% | 1785.60 | 1740 / 2642 | 92% | 19.88 | 648 / 705 |
| prostate | 85% | 2634.24 | 209 / 245 | 60% | 33.12 | 302 / 502 |
| esophagus | 74% | 2945.26 | 1075 / 1445 | 70% | 14.48 | 128 / 183 |
| bladder | 95% | 3323.52 | 20 / 21 | 45% | 12.17 | 228 / 504 |
| stomach | 72% | 1707.60 | 259 / 359 | 65% | 12.24 | 186 / 286 |
| intestine | 78% | 2493.38 | 754 / 966 | 48% | 8.45 | 254 / 527 |
| uterus | 98% | 5607.16 | 166 / 170 | 24% | 4.05 | 112 / 459 |
| adipose | 100% | 17553.89 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 7959.24 | 241 / 241 | 0% | 0 | 0 / 0 |
| heart | 99% | 6579.48 | 855 / 861 | 0% | 0 | 0 / 0 |
| muscle | 97% | 3525.58 | 780 / 803 | 0% | 0 | 0 / 0 |
| pancreas | 13% | 232.49 | 41 / 328 | 80% | 15.74 | 143 / 178 |
| skin | 45% | 1201.63 | 813 / 1809 | 44% | 10.28 | 207 / 472 |
| ovary | 51% | 1471.64 | 91 / 180 | 21% | 2.38 | 90 / 430 |
| liver | 21% | 400.44 | 47 / 226 | 43% | 6.03 | 176 / 406 |
| blood vessel | 61% | 2230.99 | 808 / 1335 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 40% | 5.36 | 18 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 17% | 2.21 | 5 / 29 |
| eye | 0% | 0 | 0 / 0 | 6% | 1.24 | 5 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0048821 | Biological process | erythrocyte development |
| GO_0043031 | Biological process | negative regulation of macrophage activation |
| GO_0042116 | Biological process | macrophage activation |
| GO_0003094 | Biological process | glomerular filtration |
| GO_0071073 | Biological process | positive regulation of phospholipid biosynthetic process |
| GO_0019216 | Biological process | regulation of lipid metabolic process |
| GO_0008654 | Biological process | phospholipid biosynthetic process |
| GO_0007186 | Biological process | G protein-coupled receptor signaling pathway |
| GO_0043129 | Biological process | surfactant homeostasis |
| GO_0007189 | Biological process | adenylate cyclase-activating G protein-coupled receptor signaling pathway |
| GO_0061626 | Biological process | pharyngeal arch artery morphogenesis |
| GO_0006112 | Biological process | energy reserve metabolic process |
| GO_0042593 | Biological process | glucose homeostasis |
| GO_0045444 | Biological process | fat cell differentiation |
| GO_0007166 | Biological process | cell surface receptor signaling pathway |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0031410 | Cellular component | cytoplasmic vesicle |
| GO_0016020 | Cellular component | membrane |
| GO_0009986 | Cellular component | cell surface |
| GO_0045177 | Cellular component | apical part of cell |
| GO_0004930 | Molecular function | G protein-coupled receptor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ADGRF5 |
| Protein name | GPR116 protein Adhesion G protein-coupled receptor F5 (G-protein coupled receptor 116) |
| Synonyms | GPR116 KIAA0758 |
| Description | FUNCTION: Receptor that plays a critical role in lung surfactant homeostasis. May play a role in controlling adipocyte function. . |
| Accessions | Q4G0K7 ENST00000265417.7 [Q8IZF2-1] ENST00000283296.12 [Q8IZF2-1] Q8IZF2 |